Back to
UBS Group AG
ARWR30 quarters
Position history for
UBS Group AG's holdings in ARROWHEAD PHARMACEUTICALS IN
UBS Group AG holds 861,520 shares of ARWR (ARROWHEAD PHARMACEUTICALS IN), worth $70.2M as of 2026-Q2. The position was decreased (-35.5% shares). ARWR represents 0.0% of UBS Group AG's portfolio.
Current Value
$70.2M
Current Shares
861,520
Total Value Change
+$69.2M
Total Shares Change
+806,906
Quarter-by-Quarter History
Other major holders of ARWR: BNP PARIBAS FINANCIAL MARKETS, BlackRock, Inc., VANGUARD GROUP INC